| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Academia isn’t so bad either
|
Moore, N.D.
|
|
2013
|
35 |
8S |
p. e122
|
artikel
|
| 2 |
Acetaminophen-induced liver injury in experimental animals and humans
|
Jaeschke, H.
|
|
2013
|
35 |
8S |
p. e119
|
artikel
|
| 3 |
Advances in genomics of blood pressure—time for translation
|
Caulfield, M.
|
|
2013
|
35 |
8S |
p. e114
|
artikel
|
| 4 |
Anti-angiogenic therapy: New insights
|
Ferrara, N.
|
|
2013
|
35 |
8S |
p. e109
|
artikel
|
| 5 |
Anti-TNF in ocular diseases
|
Süveges, I.
|
|
2013
|
35 |
8S |
p. e130
|
artikel
|
| 6 |
Assessment of drug-induced liver injury from clinical trial data
|
Merz, M.
|
|
2013
|
35 |
8S |
p. e121
|
artikel
|
| 7 |
A systematic follow-up of student-prescribers (track): therapeutic knowledge, skills/competencies and attitude
|
Brinkman, D.
|
|
2013
|
35 |
8S |
p. e113
|
artikel
|
| 8 |
Challenges in paracetamol poisoning
|
Bateman, N.
|
|
2013
|
35 |
8S |
p. e112
|
artikel
|
| 9 |
Cioms-from clinical trials to clinical practice-recent development
|
Sjölin-Forsberg, G.
|
|
2013
|
35 |
8S |
p. e129
|
artikel
|
| 10 |
Clinical pharmacology in health care in Croatia
|
Vlahovic-Palcevski, V.
|
|
2013
|
35 |
8S |
p. e132
|
artikel
|
| 11 |
Collection and impact of patient reported outcomes
|
Viola, A.
|
|
2013
|
35 |
8S |
p. e131-e132
|
artikel
|
| 12 |
Complexity of predicting the magnitude of drug-drug interactions in an individual patient: This cannot fit to a pocket guide; ipad may be!
|
Rostami-Hodjegan, A.
|
|
2013
|
35 |
8S |
p. e126-e127
|
artikel
|
| 13 |
Developing a standardised prescription chart to reduce error
|
Routledge, P.
|
|
2013
|
35 |
8S |
p. e127
|
artikel
|
| 14 |
Development of adr reporting and monitoring in china
|
Min, Y.
|
|
2013
|
35 |
8S |
p. e121
|
artikel
|
| 15 |
Development of a UK national prescribing skills assessment
|
Maxwell, S.
|
|
2013
|
35 |
8S |
p. e121
|
artikel
|
| 16 |
Development of partnerships between the biopharmaceutical industry and the world anti-doping agency
|
Rabin, O.
|
|
2013
|
35 |
8S |
p. e125
|
artikel
|
| 17 |
Diabetes, diabetes risk factors and treatments, and breast cancer
|
Boyle, P.
|
|
2013
|
35 |
8S |
p. e133-e134
|
artikel
|
| 18 |
Disclosure
|
|
|
2013
|
35 |
8S |
p. A1
|
artikel
|
| 19 |
Doping in sport: The biomarkers are the best tools to measure its prevalence and to establish the individual monitoring of the athletes
|
Saugy, M.
|
|
2013
|
35 |
8S |
p. e127-e128
|
artikel
|
| 20 |
Drug safety in emerging countries—a perspective from nigeria
|
Isah, A.O.
|
|
2013
|
35 |
8S |
p. e118
|
artikel
|
| 21 |
Electronic solutions to safer hospital prescribing
|
Coleman, J.
|
|
2013
|
35 |
8S |
p. e114
|
artikel
|
| 22 |
ENCePP: Strengthening methodology, transparency and independence
|
Fitt, H.
|
|
2013
|
35 |
8S |
p. e116
|
artikel
|
| 23 |
Ethics and privacy of biobanks
|
Elger, B.
|
|
2013
|
35 |
8S |
p. e116
|
artikel
|
| 24 |
Gene therapy approval process at EMA
|
Ruiz, S.
|
|
2013
|
35 |
8S |
p. e127
|
artikel
|
| 25 |
Genetics of treatment response in depression
|
Drago, A.
|
|
2013
|
35 |
8S |
p. e116
|
artikel
|
| 26 |
Historical development and current state of clinical pharmacology in Russia
|
Zagorodnikova, K.
|
|
2013
|
35 |
8S |
p. e133
|
artikel
|
| 27 |
How to govern a self-powered patient: Privacy and biopower
|
Coll, S.
|
|
2013
|
35 |
8S |
p. e114-e115
|
artikel
|
| 28 |
Immune mechanisms of atherosclerosis
|
Mallat, Z.
|
|
2013
|
35 |
8S |
p. e109
|
artikel
|
| 29 |
Immunological aspects of drug hypersensitivity—from molecule to man
|
Park, K.
|
|
2013
|
35 |
8S |
p. e124
|
artikel
|
| 30 |
Industry is more fit for clinical trials than academy
|
Vas, A.
|
|
2013
|
35 |
8S |
p. e131
|
artikel
|
| 31 |
Innate immune sensing of nucleic acids and application for oligonucleotide-based immunotherapy
|
Hartmann, G.
|
|
2013
|
35 |
8S |
p. e109
|
artikel
|
| 32 |
Interferon alpha and posterior uveitis
|
Fardeau, C.
|
|
2013
|
35 |
8S |
p. e134
|
artikel
|
| 33 |
Lipid emulsion as a new antidote—current use, extension from lipophilic local anesthetics to other drugs, and state of the art
|
Bania, T.
|
|
2013
|
35 |
8S |
p. e112
|
artikel
|
| 34 |
Mediator (benfluorex), a french and worldwide public health disaster
|
Frachon, I.
|
|
2013
|
35 |
8S |
p. e116-e117
|
artikel
|
| 35 |
Medication use: From leaflet to elearning
|
Piguet, V.
|
|
2013
|
35 |
8S |
p. e125
|
artikel
|
| 36 |
Multiple sclerosis—new chances?
|
Curtin, F.
|
|
2013
|
35 |
8S |
p. e115
|
artikel
|
| 37 |
Networking for regulatory toxicology
|
Wilks, M.
|
|
2013
|
35 |
8S |
p. e132-e133
|
artikel
|
| 38 |
New developments in the treatment of inborn errors of metabolism
|
Baumgartner, M.R.
|
|
2013
|
35 |
8S |
p. e112-e113
|
artikel
|
| 39 |
New insights into the mechanisms of dioxin toxicity in humans
|
Saurat, J.-H.
|
|
2013
|
35 |
8S |
p. e128
|
artikel
|
| 40 |
New medicines for control and elimination of malaria
|
Wells, T.N.C.
|
|
2013
|
35 |
8S |
p. e132
|
artikel
|
| 41 |
New strategies in the treatment of major depression
|
Artigas, F.
|
|
2013
|
35 |
8S |
p. e111-e112
|
artikel
|
| 42 |
New targets in the treatment of rheumatoid arthritis
|
Szekanecz, Z.
|
|
2013
|
35 |
8S |
p. e130
|
artikel
|
| 43 |
Non infectious intermediate and posterior uveitis: Treatment and place of local steroids
|
Accorinti, M.
|
|
2013
|
35 |
8S |
p. e111
|
artikel
|
| 44 |
Novel antidiabetics: Should they be used at all—and in whom?
|
Meier, C.
|
|
2013
|
35 |
8S |
p. e121
|
artikel
|
| 45 |
Novel approaches in the treatment of dyslipidemias
|
Stalenhoef, A.F.
|
|
2013
|
35 |
8S |
p. e129-e130
|
artikel
|
| 46 |
Novel clinical trial designs for assessing the efficacy of drugs
|
Parmar, M.
|
|
2013
|
35 |
8S |
p. e124
|
artikel
|
| 47 |
Novel mechanistic biomarkers of drug-induced liver injury
|
Park, K.
|
|
2013
|
35 |
8S |
p. e123-e124
|
artikel
|
| 48 |
Oc024—Addressing The Challenges Of Diabetes And Its Complication: The Imi Diabetes Platform
|
Jablonka, B.
|
|
2013
|
35 |
8S |
p. e10
|
artikel
|
| 49 |
OC009—An Assessment Of The Accuracy Of Horizon Scanning Predictions Of Medicine Use In The Scottish National Health Service
|
Bennie, M.
|
|
2013
|
35 |
8S |
p. e4-e5
|
artikel
|
| 50 |
Oc028—A New Pharmaceutical Form Of Paracetamol: Efficacy Of Transmucous Buccal Paracetamol In Acute Pain Patients
|
Pickering, G.
|
|
2013
|
35 |
8S |
p. e11-e12
|
artikel
|
| 51 |
OC001—A Promising Predictor For Heart Diseases And Diuretic Drug Therapy In The Aldosterone Receptor Gene
|
Dalila, N.
|
|
2013
|
35 |
8S |
p. e1
|
artikel
|
| 52 |
Oc013—A Simplified Method For Busulfan Therapeutic Drug Monitoring Using Dried Blood Spot Sampling In Pediatric Patient Undergoing Stem Cell Transplantation
|
Uppugunduri, C.R.S.
|
|
2013
|
35 |
8S |
p. e5-e6
|
artikel
|
| 53 |
OC007—Assessment Of Clinical Pharmacology Skills As Part Of The New Integrated Final Exam For Medical Students At Karolinska Institutet
|
Ovesjö, M.-L.
|
|
2013
|
35 |
8S |
p. e3-e4
|
artikel
|
| 54 |
OC005—Biases On The Administered Parenteral Doses Of An Experimental Drug During Phase I Clinical Trials
|
Perrottet Ries, N.
|
|
2013
|
35 |
8S |
p. e2-e3
|
artikel
|
| 55 |
Oc033—Cedia Assays For Buprenorphine, Methadone, And Eddp In Urine – Simple Methods, But Sufficient For The Purpose?
|
Berg, J.A.
|
|
2013
|
35 |
8S |
p. e13-e14
|
artikel
|
| 56 |
Oc017—Clinical And Noninterventional Trials Assessment In Croatia
|
Vitezic, D.
|
|
2013
|
35 |
8S |
p. e7
|
artikel
|
| 57 |
Oc021—Clinical Trials Registry And Good Clinical Practice: In Indian Scenario
|
Prakash, A.
|
|
2013
|
35 |
8S |
p. e9
|
artikel
|
| 58 |
OC014—Clinical Usefulness Of Therapeutic Concentration Monitoring For Imatinib Dosage Individualization: Results From The Randomized Controlled I-Come Trial
|
Gotta, V.
|
|
2013
|
35 |
8S |
p. e6
|
artikel
|
| 59 |
OC006—Critical Review Of The Validation Process Of Six Predictive Biomarkers: How Good Is The Quality And Quantity Of The Evidence?
|
Peñataro, J.S.
|
|
2013
|
35 |
8S |
p. e3
|
artikel
|
| 60 |
OC002—Cyp2r1 Genetic Polymorphisms Are Associated With Lower 25-Hydroxy Vitamin D Levels In Lebanese Subjects
|
Zgheib, N.K.
|
|
2013
|
35 |
8S |
p. e1
|
artikel
|
| 61 |
Oc023—Do Treatment Quality Indicators Predict Cardiovascular Outcomes In Patients With Diabetes?
|
Sidorenkov, G.
|
|
2013
|
35 |
8S |
p. e9-e10
|
artikel
|
| 62 |
Oc027—Dual Reuptake Inhibitor Milnacipran And Spinal Pain Pathways In Fibromyalgia Patients: A Randomized Double-Blind Placebo-Controlled Trial
|
Matthey, A.
|
|
2013
|
35 |
8S |
p. e11
|
artikel
|
| 63 |
OC004—Fetal Exposure To Nonsteroidal Antiinflammatory Drugs (Nsaid) And Spontaneous Abortions
|
Daniel, S.
|
|
2013
|
35 |
8S |
p. e2
|
artikel
|
| 64 |
Oc030—Gemfibrozil Impairs Imatinib Absorption And Inhibits The Cyp2c8-Mediated Formation Of Its Main Metabolite In Healthy Volunteers
|
Filppula, A.M.
|
|
2013
|
35 |
8S |
p. e12-e13
|
artikel
|
| 65 |
Oc031—Generic Substitution Of Antiepileptic Drug (Aed) And Loss Of Seizure Control: A Population-Based Case-Crossover Study
|
Polard, E.
|
|
2013
|
35 |
8S |
p. e13
|
artikel
|
| 66 |
Oc026—Impact Of Circulating Levels Of Interleukin-17 And Cardiovascular Outcomes In Patients With Acute Myocardial Infarction
|
Simon, T.
|
|
2013
|
35 |
8S |
p. e11
|
artikel
|
| 67 |
OC036—Impact Of Cyp2c9 Polymorphisms On The Vulnerability To Pharmacokinetic Drug–Drug Interactions During Acenocoumarol Treatment
|
Rollason, V.
|
|
2013
|
35 |
8S |
p. e14
|
artikel
|
| 68 |
OC038—Indications And Dosages Of Atypical Antipsychotics In Belgian Nursing Homes
|
Azermai, M.
|
|
2013
|
35 |
8S |
p. e15
|
artikel
|
| 69 |
Oc029—Interaction Between Mycophenolate Mophetil And Tacrolimus In Kidney Graft Recipients
|
Strojil, J.
|
|
2013
|
35 |
8S |
p. e12
|
artikel
|
| 70 |
Oc022—Interchangeability Of Gabapentin Generic Formulations In The Netherlands: A Comparative Bioavailability Study
|
Maliepaard, M.
|
|
2013
|
35 |
8S |
p. e9
|
artikel
|
| 71 |
OC019—Intrapulmonary Pharmacokinetics (Pk) And The Intracellular Disposition To Support The Long-Lasting Efficacy After An Inhaled Administration Of Its Prodrug Laninamivir Octanoate (Lo)
|
Toyama, K.
|
|
2013
|
35 |
8S |
p. e8
|
artikel
|
| 72 |
Oc016—Off-Label Use And Adverse Events Of Biologic Agents In Paediatric Patients With Juvenile Idiopathic Arthritis
|
Broe, J.
|
|
2013
|
35 |
8S |
p. e7
|
artikel
|
| 73 |
Oc020—Optimal Sampling Strategy For Busulfan In Stem Cell Transplantation Patients
|
Castro, F.A.
|
|
2013
|
35 |
8S |
p. e8-e9
|
artikel
|
| 74 |
OC011—Patented Drug Extension Strategies On Health Care Spending: A Cost-Evaluation Analysis
|
Vernaz, N.
|
|
2013
|
35 |
8S |
p. e5
|
artikel
|
| 75 |
OC003—Pregnancy Outcome Following Maternal Exposure To Mirtazapine: Preliminary Results Of A Collaborative Entis Study
|
Winterfeld, U.
|
|
2013
|
35 |
8S |
p. e1-e2
|
artikel
|
| 76 |
Oc025—Reversal Strategy In Antagonizing The P2y12-Inhibitor Ticagrelor
|
Hobl, E.-L.
|
|
2013
|
35 |
8S |
p. e10-e11
|
artikel
|
| 77 |
OC035—Self-Empowering Patients—A Promising Example In Oral Anticoagulation
|
Vormfelde, S.V.
|
|
2013
|
35 |
8S |
p. e14
|
artikel
|
| 78 |
OC037—Sleep Quality Of Chronic Benzodiazepine Users In Nursing Homes: A Comparative Study With Non-Users
|
Bourgeois, J.
|
|
2013
|
35 |
8S |
p. e14-e15
|
artikel
|
| 79 |
Oc008—The Effect Of A Structured Medical Record On The Recording Of Therapeutic Information And Communication Between Doctors
|
Van Unen, R.
|
|
2013
|
35 |
8S |
p. e4
|
artikel
|
| 80 |
Oc018—The Number Of Included Older People In Recent Pre-Authorisation Trials
|
Beers, E.
|
|
2013
|
35 |
8S |
p. e7-e8
|
artikel
|
| 81 |
Oc015—Up-Titration Study With Ponesimod, A Selective S1p1 Receptor Modulator, To Assess Its Maximum Tolerated Dose In Healthy Subjects
|
Hoch, M.
|
|
2013
|
35 |
8S |
p. e6-e7
|
artikel
|
| 82 |
Overview of pharmacovigilance in resource limited settings: Challenges and opportunities
|
Olsson, S.
|
|
2013
|
35 |
8S |
p. e122-e123
|
artikel
|
| 83 |
Pharmacogenetics and other factors in individualization of oral anti-vitamine k anti-coagulants
|
Beaune, P.
|
|
2013
|
35 |
8S |
p. e113
|
artikel
|
| 84 |
Pharmacology of chocolate
|
Pichard, C.
|
|
2013
|
35 |
8S |
p. e124-e125
|
artikel
|
| 85 |
Population pharmacogenetics and its impact for pharmacovigilance
|
LLerena, A.
|
|
2013
|
35 |
8S |
p. e120-e121
|
artikel
|
| 86 |
PP146—ABCB1 C3435T Polymorphism is Associated with Susceptibility to Major Depression but not Clinical Response to Citalopram in Turkish Population
|
Ozbey, G.
|
|
2013
|
35 |
8S |
p. e63-e64
|
artikel
|
| 87 |
PP069—ABCD(2) risk scoring is not an effective triage tool for predicting need for urgent treatment in patients with symptomatic cerebral microemboli or critical carotid artery stenosis
|
Saedon, M.
|
|
2013
|
35 |
8S |
p. e39
|
artikel
|
| 88 |
PP068—A cross-sectional pilot study assessing needs for and attitudes to implementation of information and communication technology for rational use of medicines among healthcare staff in rural Tanzania
|
Nilseng, J.
|
|
2013
|
35 |
8S |
p. e38-e39
|
artikel
|
| 89 |
PP231—Acute human toxicity of thiopurines, mycophenolate and sirolimus
|
Gregoriano, C.
|
|
2013
|
35 |
8S |
p. e91-e92
|
artikel
|
| 90 |
PP232—Acute toxicity profile of pipamperone in overdose: A consecutive case series
|
Hofer, K.E.
|
|
2013
|
35 |
8S |
p. e92
|
artikel
|
| 91 |
PP001—ADherence and self-reported medication-related morbidity: A population-based study
|
Hedna, K.
|
|
2013
|
35 |
8S |
p. e17
|
artikel
|
| 92 |
PP024—Adverse drug events and medication errors related to psychotropic drugs in patients presenting at an emergency department
|
Pfistermeister, B.
|
|
2013
|
35 |
8S |
p. e24-e25
|
artikel
|
| 93 |
PP228—Adverse reactions in children are not the same in adults: Analysis of spontaneous reports in 2011-2012 in Crimea, Ukraine
|
Matvieiev, O.V.
|
|
2013
|
35 |
8S |
p. e90-e91
|
artikel
|
| 94 |
PP084—A European score predicts better south american cardiovascular risk than framingham risk equations
|
Marchant, I.
|
|
2013
|
35 |
8S |
p. e44
|
artikel
|
| 95 |
PP064—Agranulocytosis detection outcome by clozapine treatment (ADOC study) in psychiatry: A cost-effectiveness study
|
Girardin, F.R.
|
|
2013
|
35 |
8S |
p. e37-e38
|
artikel
|
| 96 |
PP138—Analysis of CYP2D6 genetic polymorphisms in mexican mestizos, lacandones and tzeltales
|
Lopez Lopez, M.
|
|
2013
|
35 |
8S |
p. e59
|
artikel
|
| 97 |
PP065—An investigation of the horizon scanning approach used for new medicines in the scottish national health service
|
Bennie, M.
|
|
2013
|
35 |
8S |
p. e38
|
artikel
|
| 98 |
PP201—An Open-Label, Randomized, Single-Centre, Four-Way Crossover Study to Evaluate the Pharmacokinetics of Single, Oral Doses of Retigabine/Ezogabine in Healthy Adult Taiwanese Subjects
|
Buraglio, M.
|
|
2013
|
35 |
8S |
p. e80
|
artikel
|
| 99 |
PP032—Antidepressant prescription by gauteng dispensing doctors
|
Moch, S.
|
|
2013
|
35 |
8S |
p. e27-e28
|
artikel
|
| 100 |
PP178—Antiepileptic Drugs: Prescribing Patterns and Interaction Risk in General Practice
|
Italiano, D.
|
|
2013
|
35 |
8S |
p. e73-e74
|
artikel
|
| 101 |
PP189—A Physiologically-Based Mechanistic Pharmacokinetic Model to Assess the Metabolism of Oxycodone in Healthy Volunteers: Interplay Between CYP3A and 2D6 Inhibition
|
Marsousi, N.
|
|
2013
|
35 |
8S |
p. e76
|
artikel
|
| 102 |
PP144—Assessing In Vivo Enzyme Genetic Variation in the Presence of Transporter Effect
|
Chauhan, R.
|
|
2013
|
35 |
8S |
p. e63
|
artikel
|
| 103 |
PP139—Association of ABCB1, ABCC2, CYP2C9 and CYP2C19 polymorphism with phenytoin plasma concentrations
|
Ortega Vázquez, A.
|
|
2013
|
35 |
8S |
p. e59-e60
|
artikel
|
| 104 |
PP168—A Survey on a Clinical Research Information Portal Site for the General Public in Japan
|
Arita, E.
|
|
2013
|
35 |
8S |
p. e71
|
artikel
|
| 105 |
PP048—A systematic review on learning in a student run clinic
|
Schutte, T.
|
|
2013
|
35 |
8S |
p. e33
|
artikel
|
| 106 |
PP265—Attenuation of aluminium induced neurodegeneration by 4-methylesculetin
|
Shirole, T.
|
|
2013
|
35 |
8S |
p. e100-e101
|
artikel
|
| 107 |
PP226—Available and clinically applicable information for rational prescribing to older patients in European and American handbooks
|
Boer, J.L.
|
|
2013
|
35 |
8S |
p. e89-e90
|
artikel
|
| 108 |
PP278—Bile acid induced changes in the expression of mirnas and genes involved in drug metabolism and disposition
|
Mwinyi, J.
|
|
2013
|
35 |
8S |
p. e105
|
artikel
|
| 109 |
PP212—Bioavailability of Digoxin Tablets, Low Therapeutic Index Drug, Determined by Emit
|
Duda, J.
|
|
2013
|
35 |
8S |
p. e84
|
artikel
|
| 110 |
PP280—Blood levels of cyclosporine a and its first line metabolites during an early fase after renal transplantation in patients with normal and delayed graft function
|
Grundmann, M.
|
|
2013
|
35 |
8S |
p. e106
|
artikel
|
| 111 |
PP249—BRINAVESS® – arguments of regulatory suspension in Serbia
|
Stanimirovic, V.
|
|
2013
|
35 |
8S |
p. e97
|
artikel
|
| 112 |
PP262—Can authorities take full advantage of the availability of generic atypical antipsychotic drugs? implications for the future
|
Godman, B.
|
|
2013
|
35 |
8S |
p. e99-e100
|
artikel
|
| 113 |
PP202—Cancer Cachexia Raises the Plasma Concentration of Oxymorphone Through the Reduction of CYP3A but not CYP2D6 in Oxycodone-Treated Patients
|
Naito, T.
|
|
2013
|
35 |
8S |
p. e80-e81
|
artikel
|
| 114 |
PP279—Cardio-hepatic syndrome and therapeutic efficacy of nad-containing drug
|
Gongadze, N.V.
|
|
2013
|
35 |
8S |
p. e105-e106
|
artikel
|
| 115 |
PP053—Challenges in undergraduate pharmacotherapy education: The ghent university experience
|
Van Bortel, L.M.
|
|
2013
|
35 |
8S |
p. e33-e34
|
artikel
|
| 116 |
PP063—Changes in the utilisation of venlafaxine after the introduction of generics in Sweden: Implications for other countries
|
Godman, B.
|
|
2013
|
35 |
8S |
p. e37
|
artikel
|
| 117 |
PP092—Changes in vascular reactivity caused by angiotensin II in isolated vessels of rat aorta in a model of hypertension
|
Lopez-Calderon, E.M.
|
|
2013
|
35 |
8S |
p. e46
|
artikel
|
| 118 |
PP120—Chemotherapeutic antitumor activities of curcumin
|
El-Medany, A.M.
|
|
2013
|
35 |
8S |
p. e52
|
artikel
|
| 119 |
PP275—Chitosan/polymer nanoparticulate controlled release system for ibuprofen
|
Tamba, B.I.
|
|
2013
|
35 |
8S |
p. e104
|
artikel
|
| 120 |
PP257—Chlorogenic acid as potential anti-inflammatory analgesic agent
|
El-Medany, A.M.
|
|
2013
|
35 |
8S |
p. e98
|
artikel
|
| 121 |
PP227—Chronic treatment with pravastatin improves the impaired nitric oxide –mediated neurogenic and endothelium-dependent relaxation of corpus cavernosum in aged rats
|
Dalaklioglu, S.
|
|
2013
|
35 |
8S |
p. e90
|
artikel
|
| 122 |
PP107—Chronic treatment with taurine ameliorates diabetes-induced dysfunction of nitric oxide-mediated neurogenic and endothelium-dependent corpus cavernosum relaxation in rats
|
Dalaklioglu, S.
|
|
2013
|
35 |
8S |
p. e49
|
artikel
|
| 123 |
PP015—Chronotherapy with docetaxel, cisplatin, and 5-fluorouracil (5-FU) in patients with oral squamous cell carcinoma
|
Ioka, Y.
|
|
2013
|
35 |
8S |
p. e21-e22
|
artikel
|
| 124 |
PP006—Clinical disintegration time and volume of water required for orally disintegrating tablets in healthy volunteers
|
Uchida, S.
|
|
2013
|
35 |
8S |
p. e18-e19
|
artikel
|
| 125 |
PP256—Comparative study between angiotensin inhibitors & their receptor blockers on ulcerative colitis in rats
|
Elmedany, J.H.
|
|
2013
|
35 |
8S |
p. e98
|
artikel
|
| 126 |
PP078—Comparison of a new elisa-based with the flow cytometric assay for vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation to assess P2Y12-inhibition after ticagrelor intake
|
Hobl, E.-L.
|
|
2013
|
35 |
8S |
p. e42
|
artikel
|
| 127 |
PP161—Comparison of Effect of Raloxifene on the Coagulation and Fibrinolytic Systems Between Morning and Evening Dosing Regimens in Post-Menopausal Women with Osteoporosis
|
Ushijima, K.
|
|
2013
|
35 |
8S |
p. e68
|
artikel
|
| 128 |
PP176—Comparison of Inhibitory Duration of Grapefruit Juice on Organic Anion-Transporting Polypeptide and CYP3A4
|
Tanaka, S.
|
|
2013
|
35 |
8S |
p. e72-e73
|
artikel
|
| 129 |
PP205—Comparison of Pharmacodynamic Effect of Two Different Modified-Release Oral Diltiazem Formulations
|
Bogiel, M.
|
|
2013
|
35 |
8S |
p. e82
|
artikel
|
| 130 |
PP091—Complex regulation of alpha-adrenoceptor-mediated vasoconstriction in human internal thoracic arteries
|
Wilkins, L.E.
|
|
2013
|
35 |
8S |
p. e45-e46
|
artikel
|
| 131 |
PP270—Computational modeling of dravet syndrome
|
Kurbatova, P.
|
|
2013
|
35 |
8S |
p. e102
|
artikel
|
| 132 |
PP132—Contribution of genetic (CYP3A5, ABCB1 and POR) and non-genetic variables to the oral tacrolimus clearance in children’s with stable kidney transplant, during advagraf® treatment
|
Almeida-Paulo, G.N.
|
|
2013
|
35 |
8S |
p. e56-e57
|
artikel
|
| 133 |
PP217—Correlation between in vitro tests for blood brain barrier penetration with in vivo gliclazide penetration
|
Lalic-Popovic, M.
|
|
2013
|
35 |
8S |
p. e87
|
artikel
|
| 134 |
PP213—Correlation of Dissolution Data with Clinical Efficacy of Two Lamotrigine Tablet Formulation
|
Lalic-Popovic, M.
|
|
2013
|
35 |
8S |
p. e84-e85
|
artikel
|
| 135 |
PP159—C677T Polymorphism of Methylenetetrahydrofolate Reductase and Homocysteine Concentration in Patients with Essential Hypertension
|
Sidorenkova, N.B.
|
|
2013
|
35 |
8S |
p. e68
|
artikel
|
| 136 |
PP233—CYP1A activity after chronic exposure to dioxins from a waste incinerator
|
Samer, C.
|
|
2013
|
35 |
8S |
p. e92-e93
|
artikel
|
| 137 |
PP157—CYP2C9 Allele Frequencies Among Three Costa Rican Ethnic Groups Compared With Hispanic Populations
|
Céspedes-Garro, C.
|
|
2013
|
35 |
8S |
p. e67-e68
|
artikel
|
| 138 |
PP121—CYP2C9 genotypes associated with higher sulfolane levels in children receiving intravenous busulfan prior to hematopoietic stem cell transplantation
|
Uppugunduri, C.R.S.
|
|
2013
|
35 |
8S |
p. e52-e53
|
artikel
|
| 139 |
PP147—CYP2D6 Genetic Polymorphisms Among Three Costa Rican Populations
|
Céspedes Garro, C.
|
|
2013
|
35 |
8S |
p. e64
|
artikel
|
| 140 |
PP156—CYP2D6 Genotypes and Prediction of Metabolic Profiles in the Portuguese Population: Clinical Implications
|
Albuquerque, J.
|
|
2013
|
35 |
8S |
p. e67
|
artikel
|
| 141 |
PP127—CYP4F2 and apoe contribution in acenocoumarol dosing based on genotype: A comparison of two algorithms
|
Tong, H.Y.
|
|
2013
|
35 |
8S |
p. e54-e55
|
artikel
|
| 142 |
PP173—Cytisin Amidophosphate Shows Hepatoprotective Effect
|
Nurgozhin, T.
|
|
2013
|
35 |
8S |
p. e72
|
artikel
|
| 143 |
PP083—Dabigatran– demonstrates the need for comprehensive approaches to optimise the use of new drugs
|
Malmstrom, R.E.
|
|
2013
|
35 |
8S |
p. e43-e44
|
artikel
|
| 144 |
PP208—Deoxycholic Acid as a Modifier of the Blood Brain Barrier Permeation in Rat
|
Lalic-Popovic, M.
|
|
2013
|
35 |
8S |
p. e83
|
artikel
|
| 145 |
PP009—Development, validation and usability of software to calculate the drug burden index: A pilot study
|
Kouladjian, L.
|
|
2013
|
35 |
8S |
p. e19
|
artikel
|
| 146 |
PP039—Difficulties in pharmacovigilance practices in european non-eu countries and their differences from eu requirements
|
Vukovic, J.
|
|
2013
|
35 |
8S |
p. e29-e30
|
artikel
|
| 147 |
PP164—Dipyridamole Does Not Limit Myocardial Ischemia-Reperfusion Injury After Coronary Artery Bypass Grafting Regardless AMPD1 Genotype
|
El Messaoudi, S.
|
|
2013
|
35 |
8S |
p. e69-e70
|
artikel
|
| 148 |
PP145—Distribution of Genetic Variants of CYP2D6 in Amerindians from Northwest Mexico
|
Lazalde-Ramos, B.P.
|
|
2013
|
35 |
8S |
p. e63
|
artikel
|
| 149 |
PP047—Do junior doctors have enough ready knowledge of the drugs they prescribe?
|
Jansen, B.H.-E.
|
|
2013
|
35 |
8S |
p. e32-e33
|
artikel
|
| 150 |
PP066—Do the antibiotics bought without prescription influences the total amount of antibiotics?
|
Horvat, O.
|
|
2013
|
35 |
8S |
p. e38
|
artikel
|
| 151 |
PP031—Drug-associated acute liver failure leading to registration for transplantation in france from the study of acute liver transplant (SALT)
|
Gulmez, E.
|
|
2013
|
35 |
8S |
p. e27
|
artikel
|
| 152 |
PP027—Drug-induced liver injury detected through a pharmacovigilance program based in laboratory signals
|
Tong, H.Y.
|
|
2013
|
35 |
8S |
p. e26
|
artikel
|
| 153 |
PP268—Drug-induced long QT in adult psychiatric inpatients: The 5-year cross-sectional ESOP study
|
Girardin, F.R.
|
|
2013
|
35 |
8S |
p. e101
|
artikel
|
| 154 |
PP040—Drug information unit–valuable source of information, novi sad experience
|
Vukmirovic, S.
|
|
2013
|
35 |
8S |
p. e30
|
artikel
|
| 155 |
PP008—Drug-related problems in a general internal medicine service
|
Guignard, B.
|
|
2013
|
35 |
8S |
p. e19
|
artikel
|
| 156 |
PP221—Drug use in the paediatric wards in denmark – a nationwide study with focus on legislation
|
Haslund-Krog, S.S.
|
|
2013
|
35 |
8S |
p. e88
|
artikel
|
| 157 |
PP166—Effect of Carvedilol Versus Carvedilol/Ivabradine Combination on Heart Rate, Quality of Life, Morbidity and Mortality in Patients with Stable Ischemic Heart Failure
|
Al Saadi, T.
|
|
2013
|
35 |
8S |
p. e70
|
artikel
|
| 158 |
PP284—Effect of diesel exhausts particles on cisplatin-induced toxicity on human kidney cells, and the influence of curcumin thereon
|
Ali, B.H.
|
|
2013
|
35 |
8S |
p. e107
|
artikel
|
| 159 |
PP119—Effect of liposomal curcumin on red blood cells in vitro
|
Storka, A.
|
|
2013
|
35 |
8S |
p. e52
|
artikel
|
| 160 |
PP183—Effect of Ritonavir, Ketoconazole and Rifampin on Intestinal and Hepatic Cytochrome P450 3A Enzymes in Healthy Asian Adults
|
Seng, K.-Y.
|
|
2013
|
35 |
8S |
p. e75
|
artikel
|
| 161 |
PP273—Effect of the gabaa ligands clobazam and clonazepam on the modulation of pain transmission in humans: A pk-pd study
|
Besson, M.
|
|
2013
|
35 |
8S |
p. e103-e104
|
artikel
|
| 162 |
PP020—Effects of aripiprazole and risperidone on ventricular repolarization in children and adolescents
|
Italiano, D.
|
|
2013
|
35 |
8S |
p. e23-e24
|
artikel
|
| 163 |
PP103—Effects of clofibrate on ouabain-induced arrhythmia in isolated rat atria
|
Bakhtiarian, A.
|
|
2013
|
35 |
8S |
p. e48
|
artikel
|
| 164 |
PP033—Effects of pregabalin on driving
|
Nomoto, M.
|
|
2013
|
35 |
8S |
p. e28
|
artikel
|
| 165 |
PP137—Effects of the genetic polymorphisms of human multidrug and toxin extrusion 1 (HMATE1/SLC47A1) transporter on the renal tubular secretion of N1-methylnicotinamide
|
Ogawa, R.
|
|
2013
|
35 |
8S |
p. e58-e59
|
artikel
|
| 166 |
PP196—Enantioselective Metabolism of Venlafaxine in Healthy Volunteers and in Patients with Psoriasis
|
Lanchote, V.L.
|
|
2013
|
35 |
8S |
p. e78-e79
|
artikel
|
| 167 |
PP077—Endothelial dysfunction due to ischemia-reperfusion injury is not prevented by metformin therapy in healthy volunteers
|
Elmessaoudi, S.
|
|
2013
|
35 |
8S |
p. e41-e42
|
artikel
|
| 168 |
PP134—Esomeprazole used as a booster in a HIV ultrarapid CYP2C19 metabolizer treated with voriconazole
|
Bouatou, Y.
|
|
2013
|
35 |
8S |
p. e57-e58
|
artikel
|
| 169 |
PP252—Ethics of relationships in the sphere of pharmaceutical services
|
Abdukakharova, E.
|
|
2013
|
35 |
8S |
p. e97
|
artikel
|
| 170 |
PP081—Evaluation of hypoglycemic activity of a novel long acting insulin analogue
|
Pawłowska, M.
|
|
2013
|
35 |
8S |
p. e42-e43
|
artikel
|
| 171 |
PP165—Evaluation of JNJ-26489112, a Novel Antiepileptic Drug: A Placebo-Controlled, Exploratory Study
|
Kasteleijn-Nolst Trenité, D.
|
|
2013
|
35 |
8S |
p. e70
|
artikel
|
| 172 |
PP237—EVALUATION OF THE EFFECT OF DIMETHOATE INTOXICATION ON MALE RAT REPRODUCTIVE PERFORMANCES
|
El-Medany, J.M.
|
|
2013
|
35 |
8S |
p. e93-e94
|
artikel
|
| 173 |
PP130—Evaluation of the influence of cytocrome P450 oxidoreductase (POR) in the stable dose of acenocoumarol
|
Borobia, A.M.
|
|
2013
|
35 |
8S |
p. e56
|
artikel
|
| 174 |
PP181—Evaluation of the Interaction Between Methotrexate and Proton Pump Inhibitors Using Human OAT1 And OAT3 Hek Transfected Cells
|
Chioukh, R.
|
|
2013
|
35 |
8S |
p. e74-e75
|
artikel
|
| 175 |
PP153—Evaluation of the Relationships Between ABCB1 C3435T and G2677T/A Polymorphisms and Clinical Response to Venlafaxine in Patients with Major Depressive Disorder
|
Ozbey, G.
|
|
2013
|
35 |
8S |
p. e66
|
artikel
|
| 176 |
PP175—Evidence of Drug–Drug Interactions Through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications For Cellular Concentrations Of Competing Drugs
|
Daali, Y.
|
|
2013
|
35 |
8S |
p. e72
|
artikel
|
| 177 |
PP016—Exposure to antipsychotics with pro-arrhythmic risk: Combining adverse drug reactions with drug utilization data
|
Raschi, E.
|
|
2013
|
35 |
8S |
p. e22
|
artikel
|
| 178 |
PP136—Genetic polymorphism of CYP2D6 significantly affects the pharmacokinetics of tolperisone
|
Byeon, J.
|
|
2013
|
35 |
8S |
p. e58
|
artikel
|
| 179 |
PP023—Hemodialysis for cefepime intoxication: A case report
|
Mani, L.-Y.
|
|
2013
|
35 |
8S |
p. e24
|
artikel
|
| 180 |
PP036—Hepatotoxicity in acute and repeated supratherapeutic paracetamol ingestion in children and adolescents. retrospective cohort study conducted between 2005 and 2010
|
Tong, H.Y.
|
|
2013
|
35 |
8S |
p. e28
|
artikel
|
| 181 |
PP070—Hospital infections in internal medicine intensive care clinic: Incidence, causative agents and antimicrobial consumption
|
Miljkovic, M.
|
|
2013
|
35 |
8S |
p. e39-e40
|
artikel
|
| 182 |
PP179—Identification of Drug–Drug Interactions Through a Digital Health Service
|
Ussai, S.
|
|
2013
|
35 |
8S |
p. e74
|
artikel
|
| 183 |
PP255—IFN-gamma interfere the effect of beta-2 agonist on tnf-alpha induced CXCL10 through creb phosphorylation in HASM cells
|
Jindarat, S.
|
|
2013
|
35 |
8S |
p. e97-e98
|
artikel
|
| 184 |
PP143—Impact of UGT1A4 genotype in the clinical response to lamotrigine in patients with epilepsy
|
Ortega Vázquez, A.
|
|
2013
|
35 |
8S |
p. e61
|
artikel
|
| 185 |
PP128—Impact of variability in the brain-derived neurotrophic factor (BDNF) gene in eating disorder patients
|
Gamero, C.
|
|
2013
|
35 |
8S |
p. e55
|
artikel
|
| 186 |
PP263—Importance of TDM, phenotyping and genotyping during intoxication with venlafaxine
|
Kacirova, I.
|
|
2013
|
35 |
8S |
p. e100
|
artikel
|
| 187 |
PP266—Improved behaviour of APPsw 2576 Alzheimer’s disease transgenic mice on long term supplementation of figs in their diet
|
Essa, M.
|
|
2013
|
35 |
8S |
p. e101
|
artikel
|
| 188 |
PP025—Improving hy’s law definition to better predict the risk of developing acute liver failure in drug-induced liver injury (DILI)
|
Robles-Díaz, M.
|
|
2013
|
35 |
8S |
p. e25
|
artikel
|
| 189 |
PP004—Incomplete generic substitution, patient co-payment and adherence to SSRIs in Estonia
|
Rootslane, L.
|
|
2013
|
35 |
8S |
p. e17-e18
|
artikel
|
| 190 |
PP277—Increase in morphine analgesic effect when co-administrated with bile acid derivates
|
Vasovic, V.
|
|
2013
|
35 |
8S |
p. e104-e105
|
artikel
|
| 191 |
PP148—Influence of CYP2C9 IVS8-109A>T Polymorphism on Losartan Oxidation in Healthy Ecuadorians
|
Dorado, P.
|
|
2013
|
35 |
8S |
p. e64-e65
|
artikel
|
| 192 |
PP028—Influence of pharmacological education on awareness of the risk of adverse drug reactions
|
Mugosa, S.
|
|
2013
|
35 |
8S |
p. e26
|
artikel
|
| 193 |
PP142—Influence of the CYP2D6 -1584C>G promoter polymorphism on the phenotype of debrisoquine in healthy volunteers from Cuba and Nicaragua
|
Naranjo, M.E.G.
|
|
2013
|
35 |
8S |
p. e60-e61
|
artikel
|
| 194 |
PP191—Influence of Verapamil on the Pharmacokinetics of Oxcarbazepine and 10-Hydroxycarbazepine Enantiomers in Healthy Volunteers
|
Antunes, N.D.J.
|
|
2013
|
35 |
8S |
p. e76-e77
|
artikel
|
| 195 |
PP177—Inhibitory Interaction of 125 Drugs with the Renally Expressed Organic Cation Transporter OCT2: Development of a Chemoinformatics-Based Model to Predict Transporter Inhibition in Silico
|
Münch, K.
|
|
2013
|
35 |
8S |
p. e73
|
artikel
|
| 196 |
PP037—Injection of pharmaceutical tablets of buprenorphine: Differences between subutex® and its generics
|
Bouquié, R.
|
|
2013
|
35 |
8S |
p. e28-e29
|
artikel
|
| 197 |
PP167—Integrated 14C Study Designs to Provide Intravenous PK and Human Mass Balance and Metabolism Data from a Single Protocol and a Single Regulatory Submission
|
Stevens, L.
|
|
2013
|
35 |
8S |
p. e70-e71
|
artikel
|
| 198 |
PP131—Interaction between polymorphisms in Oct2 and mate1 and metformin renal clearance
|
Hougaard Christensen, M.M.
|
|
2013
|
35 |
8S |
p. e56
|
artikel
|
| 199 |
PP269—Interest of genotype assessment in antidepressant treatment failure in psychiatric patients: A case report
|
Rodieux, F.
|
|
2013
|
35 |
8S |
p. e101-e102
|
artikel
|
| 200 |
PP234—Intoxication with atypical antipsychotics in young children: A multicentre analysis of poisons centres data
|
Meli, M.
|
|
2013
|
35 |
8S |
p. e93
|
artikel
|
| 201 |
PP199—Intracellular Concentration of Darunavir as an Indicator for the Clinical Efficacy in HIV Patients
|
Nagano, D.
|
|
2013
|
35 |
8S |
p. e79-e80
|
artikel
|
| 202 |
PP281—Intravenous streptomycin dosing regimen in a patient undergoing hemodialysis: Plasma level monitoring and pharmacokinetic simulation
|
Chtioui, H.
|
|
2013
|
35 |
8S |
p. e106
|
artikel
|
| 203 |
PP245—In-vitro bioassay of 1,5 - dimethyl citrate monohydrate; a compound isolated from the fruit of mangifera Indica (anacardiaceae)
|
Khan, F.
|
|
2013
|
35 |
8S |
p. e96
|
artikel
|
| 204 |
PP126—In-vitro reactivity of drug-specific t-cells from a HLA-A*31:01 positive carbamazepine hypersensitive patient
|
Lichtenfels, M.
|
|
2013
|
35 |
8S |
p. e54
|
artikel
|
| 205 |
PP118—In vitro study of sonodynamic and photodynamic treatment on human cancer cell lines
|
Foglietta, F.
|
|
2013
|
35 |
8S |
p. e51-e52
|
artikel
|
| 206 |
PP115—Loss of NFKB activity decreases heat shock protein levels in pancreatic cancer cells
|
Matsathit, U.
|
|
2013
|
35 |
8S |
p. e50-e51
|
artikel
|
| 207 |
PP046—Medication self-administration in hospitalised patients: An evaluation using data from an electronic prescribing and medication administration system
|
Richardson, S.J.
|
|
2013
|
35 |
8S |
p. e32
|
artikel
|
| 208 |
PP010—Medication self-administration in hospitalised patients: an evaluation using data from an electronic prescribing and medication administration system
|
Richardson, S.J.
|
|
2013
|
35 |
8S |
p. e19-e20
|
artikel
|
| 209 |
PP026—Medigenia: innovative cloud based solution for pharmacovigilance
|
Ussai, S.
|
|
2013
|
35 |
8S |
p. e25-e26
|
artikel
|
| 210 |
PP248—Melitor® – regulatory issues as prerequisite for putting drug on the market
|
Stanimirovic, V.
|
|
2013
|
35 |
8S |
p. e96-e97
|
artikel
|
| 211 |
PP274—Memantine prevents the development of neuropathic pain when given before surgery
|
Pickering, G.
|
|
2013
|
35 |
8S |
p. e104
|
artikel
|
| 212 |
PP200—Metabolic Process of Voriconazole to its N-Oxide is Saturable in Clinical dose Range
|
Yamada, T.
|
|
2013
|
35 |
8S |
p. e80
|
artikel
|
| 213 |
PP116—Metastatic breast carcinoma induces vascular endothelial dysfunction in Balb-c mice: Role of tumor necrosis factor-αlpha and nadph-oxidase
|
Dalaklioglu, S.
|
|
2013
|
35 |
8S |
p. e51
|
artikel
|
| 214 |
PP204—Methadone Kinetics and Corrected QT Time During Haemodialysis in Four Methadone Maintenance Treatment Patients with End-Stage Renal Failure
|
Opdal, M.S.
|
|
2013
|
35 |
8S |
p. e81-e82
|
artikel
|
| 215 |
PP264—4-Methylesculetin a dual acting inhibitor of acetylcholinesterase and xanthine oxidase
|
Shirole, T.
|
|
2013
|
35 |
8S |
p. e100
|
artikel
|
| 216 |
PP272—Migraine and parthenolide inhibition of transient receptor potential ankyrin 1
|
Materazzi, S.
|
|
2013
|
35 |
8S |
p. e103
|
artikel
|
| 217 |
PP209—Model-Based Analysis of the Pharmacokinetics of a Modified Release Formulation af Paracetamol After Twice Daily Dosing and Potential Implications for the Risk of Hepatotoxicity in Osteoarthritis Patients
|
Della Pasqua, O.
|
|
2013
|
35 |
8S |
p. e83
|
artikel
|
| 218 |
PP102—Molecular docking research & in-vitro analysis of novel natural and synthetic PTP 1B inhibitors as potential therapeutic target for diabetes mellitus
|
Ahmed, D.
|
|
2013
|
35 |
8S |
p. e48
|
artikel
|
| 219 |
PP283—Motor and behavioral changes in mice with cisplatin-induced acute renal failure
|
Ramkumar, A.
|
|
2013
|
35 |
8S |
p. e107
|
artikel
|
| 220 |
PP058—New medicines and development strategies necessitates change in lifelong education of clinical pharmacology
|
Kerpel-Fronius, S. -.-
|
|
2013
|
35 |
8S |
p. e35
|
artikel
|
| 221 |
PP098—Nicorandil induced endothelium-independent relaxation of arterial bypass graft
|
Marinko, M.
|
|
2013
|
35 |
8S |
p. e47
|
artikel
|
| 222 |
PP088—Nitrosonifedipine, a photodegradation product of nifedipine, suppress the progression of diabetic nephropathy with the endothelial dysfunction
|
Sakurada, T.
|
|
2013
|
35 |
8S |
p. e45
|
artikel
|
| 223 |
PP012—Not-in-trial simulations: Predicting cardiovascular risk from clinical trials to real life conditions
|
Della Pasqua, O.
|
|
2013
|
35 |
8S |
p. e21
|
artikel
|
| 224 |
PP271—Novel therapeutic strategy to prevent chemotherapy-induced persistent sensory neuropathy by TRPA1 blockade
|
Trevisan, G.
|
|
2013
|
35 |
8S |
p. e102-e103
|
artikel
|
| 225 |
PP229—Observations on the oxalis perdicaria (molina) bertero in children with the persistent malnutrition diarrhea: Randomized controlled clinical trial
|
Mollik, M.A.H.
|
|
2013
|
35 |
8S |
p. e91
|
artikel
|
| 226 |
PP113—Parenteral busulfan in myeloablative conditioning regimens for hematopoietic stem-cell transplantation (HSCT) in children
|
Janeckova, D.
|
|
2013
|
35 |
8S |
p. e49-e50
|
artikel
|
| 227 |
PP060—Patented drug extension strategies and hospital restrictive drug formulary: A cost-evaluation analysis
|
Vernaz, N.
|
|
2013
|
35 |
8S |
p. e35-e36
|
artikel
|
| 228 |
PP230—Pattern of parenteral drug prescription for children under the age of 6 in Turkey
|
Donertas, B.
|
|
2013
|
35 |
8S |
p. e91
|
artikel
|
| 229 |
PP163—PBMC Increase Sirtuin3 Protein Expression in Acute Adaptation to Hypoxia in Humans
|
Storka, A.
|
|
2013
|
35 |
8S |
p. e69
|
artikel
|
| 230 |
PP223—Perceptions towards benzodiazepine discontinuation in nursing homes
|
Bourgeois, J.
|
|
2013
|
35 |
8S |
p. e88-e89
|
artikel
|
| 231 |
PP055—Persistent fever in a woman following right knee hemiarthroplasty
|
Eng, P.C.
|
|
2013
|
35 |
8S |
p. e34
|
artikel
|
| 232 |
PP154—Personalising Health Care: Feasibility and Future Implications for All Stakeholder Groups Including Authorities, Physicians and Patients
|
Godman, B.
|
|
2013
|
35 |
8S |
p. e66-e67
|
artikel
|
| 233 |
PP240—Pharmaceutical quality of generic levodopa/benserazide products
|
Vital-Durand, G.L.
|
|
2013
|
35 |
8S |
p. e94-e95
|
artikel
|
| 234 |
PP133—Pharmacogenetics of the human serotonin transporter
|
Münch, K.
|
|
2013
|
35 |
8S |
p. e57
|
artikel
|
| 235 |
PP210—Pharmacokinetics and Pharmacodynamics Modeling to Optimize Dosage Regimens Of Sulbactam
|
Jaruratanasirikul, S.
|
|
2013
|
35 |
8S |
p. e83-e84
|
artikel
|
| 236 |
PP198—Pharmacokinetics of Imipenem in the Treatment of Nosocomial Pneumonia: Comparison of 0.5 Hr and 3 Hr Infusion
|
Suchánková, H.
|
|
2013
|
35 |
8S |
p. e79
|
artikel
|
| 237 |
PP194—Pharmacokinetics of Selexipag in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy Subjects
|
Fischer, N.
|
|
2013
|
35 |
8S |
p. e77-e78
|
artikel
|
| 238 |
PP192—Pharmacokinetics of Selexipag in Subjects with Severe Renal Impairment Compared with Healthy Subjects
|
Fischer, N.
|
|
2013
|
35 |
8S |
p. e77
|
artikel
|
| 239 |
PP207—Pharmacokinetics of Sugammadex 16 Mg/Kg in Chinese Subjects
|
de Kam, P.-J.
|
|
2013
|
35 |
8S |
p. e82-e83
|
artikel
|
| 240 |
PP124—Pharmacokinetics of tolperisone in relation to CYP2C19 genotypes
|
Byeon, J.-Y.
|
|
2013
|
35 |
8S |
p. e54
|
artikel
|
| 241 |
PP215—Pharmacokinetic Study of Ganciclovir (GCV) After Single and Multiple Dose in Hematopoietic Stem Cell Transplant (Hsct) Patients with Cytomegalovirus (CMV) Infection
|
Awada, S.M.
|
|
2013
|
35 |
8S |
p. e85-e86
|
artikel
|
| 242 |
PP014—Pharmacological interventions: A way to improve the quality of antibiotic USE
|
Mas-Morey, P.
|
|
2013
|
35 |
8S |
p. e21
|
artikel
|
| 243 |
PP135—Pharmacometabolomics for individualized treatment of alcoholism: High serum glutamate level is associated with positive response to acamprosate treatment
|
Choi, D.-S.
|
|
2013
|
35 |
8S |
p. e58
|
artikel
|
| 244 |
PP029—Pharmacovigilance in crimea, Ukraine in 2012, annual report
|
Matvieiev, O.V.
|
|
2013
|
35 |
8S |
p. e26-e27
|
artikel
|
| 245 |
PP169—Pioglitazone in Mild to Moderate Ulcerative Colitis: A Placebo Controlled Randomized Trial
|
Medhi, B.
|
|
2013
|
35 |
8S |
p. e71
|
artikel
|
| 246 |
PP211—Piperine Increases Plasma Domperidone Concentrations in the Rat
|
Alhumayyd, M.
|
|
2013
|
35 |
8S |
p. e84
|
artikel
|
| 247 |
PP074—Potential effect of alpha-chymotrypcin on growth factors in alzheimer's disease model
|
Shalby, A.B.
|
|
2013
|
35 |
8S |
p. e41
|
artikel
|
| 248 |
PP241—Potential effect of the medicinal plants; calotropis procera, ficus elastica and zingiber officinale against schistosoma mansoni in mice
|
Botros, S.S.
|
|
2013
|
35 |
8S |
p. e95
|
artikel
|
| 249 |
PP100—Potential of nattokinase as an antithrombotic & fibrinolytic agent
|
Shirole, T.
|
|
2013
|
35 |
8S |
p. e47
|
artikel
|
| 250 |
PP106—Predictors for the improvement of left ventricular ejection fraction in dilated cardiomyopathy: Results from a cohort from the clinical county hospital CLUJ-napoca
|
Pop, C.
|
|
2013
|
35 |
8S |
p. e49
|
artikel
|
| 251 |
PP054—Prescribing competence in relation to conceptual and contextual teaching and learning
|
Moch, S.
|
|
2013
|
35 |
8S |
p. e34
|
artikel
|
| 252 |
PP082—Prescription of recommended drugs for acute myocardial infarction in Estonia in 2001 vs 2007 and in 2007 vs 2011
|
Marandi, T.
|
|
2013
|
35 |
8S |
p. e43
|
artikel
|
| 253 |
PP151—Prevalence of Carriage CYP2C9, VKORC1 and CYP4F2 Polymorphisms in Russian Patients With High Thrombotic Risk Prescribed Warfarin Compared With Other Ethnic Groups
|
Ivashchenko, D.
|
|
2013
|
35 |
8S |
p. e65
|
artikel
|
| 254 |
PP155—Prevalence of Gene Polymorphism SLCO1B1 in Patients with Dyslipidemia and Systemic Atherosclerosis in Russian Population
|
Sirotkina, A.
|
|
2013
|
35 |
8S |
p. e67
|
artikel
|
| 255 |
PP101—Reactivity modifications in heart resistance vessels to angiotensin II in isolated perfused heart of hypertensive rats
|
Lopez-Calderon, M.
|
|
2013
|
35 |
8S |
p. e47-e48
|
artikel
|
| 256 |
PP061—Recent reforms in scotland to take advantage of generics, their influence and implications for health authorities contemplating future reforms
|
Godman, B.
|
|
2013
|
35 |
8S |
p. e36
|
artikel
|
| 257 |
PP122—Regulation of human leukocyte antigen expression and nevirapine-induced adverse drug reactions in a malawian hiv-positive population
|
Cornejo Castro, E.M.
|
|
2013
|
35 |
8S |
p. e53
|
artikel
|
| 258 |
PP005—Risk perception and compliance in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors
|
Burdová, K.
|
|
2013
|
35 |
8S |
p. e18
|
artikel
|
| 259 |
PP180—Role of Organic Anion Transporting Polypeptides 1A2 and 2B1 in Cellular Uptake of Nadolol
|
Misaka, S.
|
|
2013
|
35 |
8S |
p. e74
|
artikel
|
| 260 |
PP042—Safety assessment of low doses of methadone in combination with benzodiazepines in real occasions during methadone maintenance treatment – A pilot study
|
Mijatović, V.
|
|
2013
|
35 |
8S |
p. e30
|
artikel
|
| 261 |
PP050—Saliva-based cyp1a2 phenotyping using caffeine from beverages: A practical course for students
|
Jetter, A.
|
|
2013
|
35 |
8S |
p. e33
|
artikel
|
| 262 |
PP002—Searching for health and medication information on the internet. A review of the literature
|
Jesaimini, A.
|
|
2013
|
35 |
8S |
p. e17
|
artikel
|
| 263 |
PP172—Short-Term Impact of Bariatric Surgery on Obesity Associated Diabetes Mellitus
|
Kumana, C.
|
|
2013
|
35 |
8S |
p. e71-e72
|
artikel
|
| 264 |
PP193—Simultaneous LC-MS/MS Quantification of P-Glycoprotein and Cytochrome P450 Probe Substrates and Their Metabolites In Dried Blood Spots
|
Bosilkovska, M.
|
|
2013
|
35 |
8S |
p. e77
|
artikel
|
| 265 |
PP038—Soy diet causes histological changes on the reproductive organs of adult male rats
|
Papaioannidou, P.
|
|
2013
|
35 |
8S |
p. e29
|
artikel
|
| 266 |
PP017—Spectrum of ocular digoxin toxicity in the elderly: A case report
|
Renard, D.
|
|
2013
|
35 |
8S |
p. e22-e23
|
artikel
|
| 267 |
PP018—Storage and wastage of antibacterial agents in households in Novi Sad, Serbia
|
Paut Kusturica, M.
|
|
2013
|
35 |
8S |
p. e23
|
artikel
|
| 268 |
PP114—Sunitinib does not reduce endothelium-dependent vasodilation in humans
|
Thijs, A.
|
|
2013
|
35 |
8S |
p. e50
|
artikel
|
| 269 |
PP239—Susceptibility of leptospira to xanthones and synergistic effects with antibiotics
|
Mekseepralard, C.
|
|
2013
|
35 |
8S |
p. e94
|
artikel
|
| 270 |
PP238—Synthesis of the five Bangladeshi unani medicines derivatives: In vitro studies of their pharmacological activities
|
Mollik, M.A.H.
|
|
2013
|
35 |
8S |
p. e94
|
artikel
|
| 271 |
PP214—Tacrolimus Blood Concentration in Patients Subjected to Renal Transplantation: The Influence of Gender
|
Rancic, N.
|
|
2013
|
35 |
8S |
p. e85
|
artikel
|
| 272 |
PP123—Target gene evaluation of two mirnas differently expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients
|
Haenisch, S.
|
|
2013
|
35 |
8S |
p. e53-e54
|
artikel
|
| 273 |
PP094—Targets of therapy of patients with congestive heart heart failure caused by ischemic heart disease and diabetes
|
Megreladze, I.I.
|
|
2013
|
35 |
8S |
p. e46-e47
|
artikel
|
| 274 |
PP152—Tendency to Higher Activity of CYP3A5 in Women with Stillbirth
|
Zagorodnikova, K.
|
|
2013
|
35 |
8S |
p. e65-e66
|
artikel
|
| 275 |
PP259—The ability of anti-S100 antibodies to ameliorate the severity of experimental allergic encephalomyelitis in wistar rats
|
Dugina, J.L.
|
|
2013
|
35 |
8S |
p. e98-e99
|
artikel
|
| 276 |
PP186—The Analysis of Interaction of Warfarin in the Real Clinical Practice
|
Barakanova, R.
|
|
2013
|
35 |
8S |
p. e75-e76
|
artikel
|
| 277 |
PP149— The Ceiba Cocktail for Drug Hydroxylation Phenotyping in Hispanic Populations
|
De Andres, F.
|
|
2013
|
35 |
8S |
p. e65
|
artikel
|
| 278 |
PP140—The contribution of platelet glycoproteins (GPIA C807T AND GPIBA C-5T) and cyclooxygenase 2 (COX-2 G--765C) polymorphisms to platelet response in patients treated with aspirin
|
Al-Azzam, S.
|
|
2013
|
35 |
8S |
p. e60
|
artikel
|
| 279 |
PP045—The effects of yarrow’s (Achillea millefolium) hydro alcoholic extract on blood proteins in mice
|
Modaresi, M.
|
|
2013
|
35 |
8S |
p. e31-e32
|
artikel
|
| 280 |
PP043—The influence of he educational and administrative measures on the trend of use of uterotonics
|
Horvat, O.
|
|
2013
|
35 |
8S |
p. e30-e31
|
artikel
|
| 281 |
PP057—The operationalization of electronic inn prescribing
|
Van Bever, E.
|
|
2013
|
35 |
8S |
p. e34-e35
|
artikel
|
| 282 |
PP243—The potential anticancer effect of azo dyes
|
Harmse, L.
|
|
2013
|
35 |
8S |
p. e95
|
artikel
|
| 283 |
PP244—Therapeutic and supra-therapeutic intravenous doses of mavoglurant (AFQ056) do not prolong the QTc interval in healthy subjects
|
Ufer, M.
|
|
2013
|
35 |
8S |
p. e95-e96
|
artikel
|
| 284 |
PP222—Therapeutic drug monitoring of daptomycin: A retrospective monocentric analysis
|
Reiber, C.
|
|
2013
|
35 |
8S |
p. e88
|
artikel
|
| 285 |
PP197—Therapeutic Drug Monitoring of Vancomycin and Aminoglycosides in an Intensive Care Unit, a Retrospective Study
|
Ing Lorenzini, K.R.
|
|
2013
|
35 |
8S |
p. e79
|
artikel
|
| 286 |
PP141—The relevance of platelet glycoprotein GP IIb/IIIa polymorphism to anti-platelets response in acute coronary syndrome[ACS]
|
Nayel, O.A.
|
|
2013
|
35 |
8S |
p. e60
|
artikel
|
| 287 |
PP220—The risk of birth defects following exposure to nitrofurantoin during first trimester
|
Goldberg, O.J.
|
|
2013
|
35 |
8S |
p. e87-e88
|
artikel
|
| 288 |
PP282—The role of cbs and H2S in the induction of torpor and organ preservation during hibernation
|
Dugbartey, G.J.
|
|
2013
|
35 |
8S |
p. e106-e107
|
artikel
|
| 289 |
PP105—The role of poly (ADP-ribose) polymerase (PARP) pathway on endothelin-1 (ET-1)-induced endothelial dysfunction in rat thoracic aorta
|
Yilmaz, B.
|
|
2013
|
35 |
8S |
p. e48-e49
|
artikel
|
| 290 |
PP080—The role of the KCNJ5 potassium channel variants in aldosterone release
|
Massimo, G.
|
|
2013
|
35 |
8S |
p. e42
|
artikel
|
| 291 |
PP117—The varying effects of pentoxifylline on cyclin D1 levels and G1 phase arrest in different renal cell carcinoma cell models
|
Mastrandrea, N.
|
|
2013
|
35 |
8S |
p. e51
|
artikel
|
| 292 |
PP090—The 3.5-year mortality impact of drugs in secondary prevention of myocardial infarction in real-life (interim analysis of the eole cohort)
|
Droz, C.
|
|
2013
|
35 |
8S |
p. e45
|
artikel
|
| 293 |
PP219—Thiopurine metabolites are useful in predicting azathioprine resistance in pediatric ibd patients
|
Nguyen, T.V.A.
|
|
2013
|
35 |
8S |
p. e87
|
artikel
|
| 294 |
PP162—Thorough QT study with ponesimod, a selective S1P1 receptor modulator
|
Hoch, M.
|
|
2013
|
35 |
8S |
p. e68-e69
|
artikel
|
| 295 |
PP011—Timeliness of medicines administration: Using data from an electronic prescribing system to monitor the quality of medicines provision
|
Thomas, S.K.
|
|
2013
|
35 |
8S |
p. e20-e21
|
artikel
|
| 296 |
PP129—Time-to-achieve stability of anticoagulation is decreased in ABCB1 mutated patients treated with acenocoumarol
|
Rollason, V.
|
|
2013
|
35 |
8S |
p. e55-e56
|
artikel
|
| 297 |
PP044—Toxicolist – A web-service to improve patient-safety
|
Ahlner, J.
|
|
2013
|
35 |
8S |
p. e31
|
artikel
|
| 298 |
PP072—Urinary tract infections treatment–prescribing patterns, guidelines, and local resistance in health centre novi sad
|
Vukmirovic, S.
|
|
2013
|
35 |
8S |
p. e41
|
artikel
|
| 299 |
PP086—Usage of antihypertensive drugs in Serbia: Age and gender stratification
|
Tomas, A.
|
|
2013
|
35 |
8S |
p. e44-e45
|
artikel
|
| 300 |
PP261—Utilization of triptanes in Sweden; analyses of over the counter and prescriptions sales
|
Von Euler, M.
|
|
2013
|
35 |
8S |
p. e99
|
artikel
|
| 301 |
PP062—Variable approaches in europe to the availability of generic losartan; implications for the future
|
Godman, B.
|
|
2013
|
35 |
8S |
p. e36-e37
|
artikel
|
| 302 |
PP022—Variations in drug-induced liver injury (DILI) between different prospective dili registries
|
Medina-Cáliz, I.
|
|
2013
|
35 |
8S |
p. e24
|
artikel
|
| 303 |
PP224—Views of clinical and non-clinical professionals on information about older patients needed for rational drug prescription at time of authorisation
|
Beers, E.
|
|
2013
|
35 |
8S |
p. e89
|
artikel
|
| 304 |
PP195—Voriconazole Adjustment from Twice to Three Times Daily in Cystic Fibrosis Lung Transplant Patients
|
Tanneau, L.
|
|
2013
|
35 |
8S |
p. e78
|
artikel
|
| 305 |
PP203—Whole Blood Cannabinoid Pharmacokinetic Parameters in Heavy and Occasional Smokers. Do Oral Fluid Cannabinoid Measurements Correlate with Whole Blood data in Heavy Smokers?
|
Fabritius, M.
|
|
2013
|
35 |
8S |
p. e81
|
artikel
|
| 306 |
Prediction of pharmacological effects of cns-active agents during early phases of drug development
|
Van Gerven, J.
|
|
2013
|
35 |
8S |
p. e131
|
artikel
|
| 307 |
Public health genomics and personalized healthcare
|
Brand, A.
|
|
2013
|
35 |
8S |
p. e113
|
artikel
|
| 308 |
Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1 using the population approach
|
Kloft, C.
|
|
2013
|
35 |
8S |
p. e119-e120
|
artikel
|
| 309 |
Risk Perception Among Health Care Professionals And The Public: Experience From Regional Medicines Information And Pharmacovigilance Centres In Norway
|
Schjott, J.
|
|
2013
|
35 |
8S |
p. e128-e129
|
artikel
|
| 310 |
Role of membrane transporters in drug interactions
|
Niemi, M.
|
|
2013
|
35 |
8S |
p. e122
|
artikel
|
| 311 |
Safety information today and how can we improve tomorrow?
|
Czarnecki, A.
|
|
2013
|
35 |
8S |
p. e115
|
artikel
|
| 312 |
Sjögren ocular disease treatment
|
Módis, L.
|
|
2013
|
35 |
8S |
p. e121-e122
|
artikel
|
| 313 |
Strategies for the development of tdm for targeted anticancer agents
|
Buclin, T.
|
|
2013
|
35 |
8S |
p. e113-e114
|
artikel
|
| 314 |
Studying teratogenic effects of medication use during pregnancy: Challenges and pitfalls
|
Van Gelder, M.
|
|
2013
|
35 |
8S |
p. e131
|
artikel
|
| 315 |
Targeted therapies in hematological malignancies
|
Hohl, R.
|
|
2013
|
35 |
8S |
p. e117-e118
|
artikel
|
| 316 |
Targets for drug development in HIV neuropathy
|
Rice, A.S.C.
|
|
2013
|
35 |
8S |
p. e126
|
artikel
|
| 317 |
The background to the new WHO/IUPHAR/CIOMS manifesto entitled “clinical pharmacology in health care, teaching and research” and the importance of the focus on health care
|
Orme, M.
|
|
2013
|
35 |
8S |
p. e123
|
artikel
|
| 318 |
The economics of personalised medicine and pharmacogenetic testing
|
Hughes, D.A.
|
|
2013
|
35 |
8S |
p. e118
|
artikel
|
| 319 |
The future of modeling and simulation approaches in drug development
|
Pfister, M.
|
|
2013
|
35 |
8S |
p. e124
|
artikel
|
| 320 |
The individualisation of cancer therapy in organ dysfunction
|
Rudek, M.
|
|
2013
|
35 |
8S |
p. e127
|
artikel
|
| 321 |
The makings of the world-class athlete: physiologic, genetic, psychosocial and economic determinants
|
Pitsiladis, Y.
|
|
2013
|
35 |
8S |
p. e125
|
artikel
|
| 322 |
The new zealand centre for adverse drug reactions monitoring: A source of practice-based evidence
|
Savage, R.L.
|
|
2013
|
35 |
8S |
p. e128
|
artikel
|
| 323 |
The poisons centres networks—toxicosurveillance
|
Desel, H.
|
|
2013
|
35 |
8S |
p. e115
|
artikel
|
| 324 |
The relevance of clinical workplace learning and assessment in CP&T
|
Dornan, T.
|
|
2013
|
35 |
8S |
p. e115-e116
|
artikel
|
| 325 |
The risk–benefit relationship as a moral compass
|
Lievre, M.
|
|
2013
|
35 |
8S |
p. e120
|
artikel
|
| 326 |
The role of modelling and simulation in clinical pharmacology
|
Aarons, L.
|
|
2013
|
35 |
8S |
p. e111
|
artikel
|
| 327 |
The role of the clinical pharmacologist in pharmacoeconomics/health economics
|
Rawlins, M.
|
|
2013
|
35 |
8S |
p. e125-e126
|
artikel
|
| 328 |
The scottish model: Scottish medicines consortium (SMC)
|
Webb, D.J.
|
|
2013
|
35 |
8S |
p. e132
|
artikel
|
| 329 |
The Swiss model of comprehensive antidote provision
|
Kupferschmidt, H.
|
|
2013
|
35 |
8S |
p. e120
|
artikel
|
| 330 |
TINN (TREAT INFECTIONS IN NEONATES): AN FP7 PROJECT
|
Jacqz-Aigrain, E.
|
|
2013
|
35 |
8S |
p. e118-e119
|
artikel
|
| 331 |
Towards best reporting practices for clinical pharmacology trials
|
Altman, D.
|
|
2013
|
35 |
8S |
p. e111
|
artikel
|
| 332 |
Transient receptor potential channels as novel drug targets
|
Geppetti, P.
|
|
2013
|
35 |
8S |
p. e117
|
artikel
|
| 333 |
Treating rare inborn errors of metabolism: From theory to practice
|
Gautschi, M.
|
|
2013
|
35 |
8S |
p. e117
|
artikel
|
| 334 |
Undergraduate training for medical students in cpt and prescribing
|
Ross, S.
|
|
2013
|
35 |
8S |
p. e126
|
artikel
|
| 335 |
Update on the status of artemisinin resistance
|
Ringwald, P.
|
|
2013
|
35 |
8S |
p. e126
|
artikel
|
| 336 |
Value-based pricing to ensure cost effective drugs for the UK NHS: Will it work?
|
Sculpher, M.
|
|
2013
|
35 |
8S |
p. e129
|
artikel
|
| 337 |
What is the additional value of electronic medical records for drug safety signal detection? The experience of eu-adr project
|
Trifiro, G.
|
|
2013
|
35 |
8S |
p. e130-e131
|
artikel
|
| 338 |
WHO programme for international drug monitoring
|
Pal, S.
|
|
2013
|
35 |
8S |
p. e123
|
artikel
|
Tijdschrift beschrijving